Bangkok Genomics Innovation PCL (BKK:BKGI) Forward Dividend Yield %: 2.48% (As of Jul. 03, 2026)


BKK:BKGI Bangkok Genomics Innovation PCL BKK:BKGI
45 GF Score
Price ฿2.10
! 12 Warning Signs
View Full Analysis

What is Bangkok Genomics Innovation PCL Forward Dividend Yield %?

Bangkok Genomics Innovation PCL BKK:BKGI +3.96% 45 Forward Dividend Yield % is 2.48% as of Jul. 03, 2026. GuruFocus rates BKK:BKGI with a GF Score™ of 45/100. The stock has 12 warning signs investors should review. Among 61 Medical Diagnostics & Research companies, Bangkok Genomics Innovation PCL ranks better than 57.38% on this metric.

As of today (2026-07-03), the Forward Annual Dividend Yield of Bangkok Genomics Innovation PCL is 2.48%.

As of today (2026-07-03), the Trailing Annual Dividend Yield of Bangkok Genomics Innovation PCL is 2.48%.

BKK:BKGI's Forward Dividend Yield % is ranked better than
57.38% of 61 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.03 vs BKK:BKGI: 2.48

Bangkok Genomics Innovation PCL's Dividends per Share for the three months ended in Dec. 2025 was ฿0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Bangkok Genomics Innovation PCL  (BKK:BKGI) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Bangkok Genomics Innovation PCL Forward Dividend Yield % Related Terms


BKK:BKGI vs TMO, DHR, IDXX: Forward Dividend Yield % Comparison

For the Diagnostics & Research subindustry, Bangkok Genomics Innovation PCL's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bangkok Genomics Innovation PCL Forward Dividend Yield % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Bangkok Genomics Innovation PCL's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Bangkok Genomics Innovation PCL's Forward Dividend Yield % falls into.


BKK:BKGI
45GF Score
Bangkok Genomics Innovation PCL BKK:BKGI
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bangkok Genomics Innovation PCL Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Bangkok Genomics Innovation PCL Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
THB 0.0500002026-05-062026-05-072026-05-28Cash DividendannuallyTHB:THB 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Bangkok Genomics Innovation PCL's Forward Annual Dividend Yield (%) for Today is calculated as

Forward Annual Dividend Yield=Forward Full Year Dividend/Current Share Price
=0.05/2.10
=2.38 %

Current Share Price is ฿2.10.
Bangkok Genomics Innovation PCL's Dividends per Share for the forward twelve months is calculated as ฿0.05 * 1 = ฿0.05.

Bangkok Genomics Innovation PCL's Trailing Annual Dividend Yield (%) for Today is calculated as

Trailing Annual Dividend Yield=Most Recent Full Year Dividend/Current Share Price
=0.05/2.10
=2.38 %

Current Share Price is ฿2.10.
Bangkok Genomics Innovation PCL's Dividends per Share for the trailing twelve months (TTM) ended in Today is ฿0.05.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Forward Dividend Yield % of 2.48% mean?
Bangkok Genomics Innovation PCL (BKK:BKGI) has a Forward Dividend Yield % of 2.48% as of Jul. 03, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Bangkok Genomics Innovation PCL and its competitors. According to the industry distribution chart, Bangkok Genomics Innovation PCL ranks #26 out of 61 companies in the Medical Diagnostics & Research industry, placing it in the top 42.6%.
Is Bangkok Genomics Innovation PCL's Forward Dividend Yield % too high?
Bangkok Genomics Innovation PCL's current Forward Dividend Yield % is 2.48%. The Medical Diagnostics & Research industry median Forward Dividend Yield % is 2.03. Bangkok Genomics Innovation PCL's value of 2.48% is 22.2% above this industry median. Based on the distribution chart, Bangkok Genomics Innovation PCL ranks #26 out of 61 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Bangkok Genomics Innovation PCL has a GF Score™ of 45/100, reflecting its overall financial health beyond just this single metric.
How does Bangkok Genomics Innovation PCL's Forward Dividend Yield % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Bangkok Genomics Innovation PCL ranks #26 out of 61 companies for Forward Dividend Yield %. This puts Bangkok Genomics Innovation PCL in the upper half of its industry. The industry median Forward Dividend Yield % is 2.03. Bangkok Genomics Innovation PCL's value of 2.48% is 22.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Medical Diagnostics & Research company?
The median Forward Dividend Yield % among Medical Diagnostics & Research companies is 2.03, based on 61 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bangkok Genomics Innovation PCL's current Forward Dividend Yield % of 2.48% is 22.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Bangkok Genomics Innovation PCL and its competitors. For the Medical Diagnostics & Research industry, the median Forward Dividend Yield % is 2.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bangkok Genomics Innovation PCL's current Forward Dividend Yield % is 2.48%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bangkok Genomics Innovation PCL stock overvalued right now?
Bangkok Genomics Innovation PCL (BKK:BKGI) has a current Forward Dividend Yield % of 2.48%. The current Forward Dividend Yield % is 2.48% and 22.2% above the Medical Diagnostics & Research industry median of 2.03. Bangkok Genomics Innovation PCL's overall GF Score™ is 45/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Bangkok Genomics Innovation PCL (BKK:BKGI), the current Forward Dividend Yield % is 2.48% as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bangkok Genomics Innovation PCL Business Description

Address 3689 Rama 4 Road, Phra Khanong Subdistrict, Khlong Toei Subdistrict, Bangkok, THA, 10110
Bangkok Genomics Innovation PCL operate a laboratory and provide medical analysis services. Its services includes Screening for genetic abnormalities in reproductive health (Reproductive Health Testing Services),Infectious Disease Analysis Product Group (Infectious - Related Testing Services), Other screening product groups (Other Testing Services), providing technology services (Tech Solution Services), and Sales of other medical products Related (Medical - Related Products). Its segments include Sale of laboratory reagents and related products; Testing and analysis services, which derives maximum revenue; and Sale and advanced therapy medicinal product.
45GF Score

Get the complete analysis for BKK:BKGI

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿2.10
Price